CLINICAL PROFILE OF PATIENTS WITH SYMPTOMATIC GLYCYRRHIZIN-INDUCED HYPOKALEMIA-Reference-Cited by-同舟云学术

CLINICAL PROFILE OF PATIENTS WITH SYMPTOMATIC GLYCYRRHIZIN-INDUCED HYPOKALEMIA

Published:2008-08 Issue:8 Volume:56 Page:1579-1581
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:

Author:

Kurisu Satoshi,Inoue Ichiro,Kawagoe Takuji,Ishihara Masaharu,Shimatani Yuji,Nakama Yasuharu,Maruhashi Tatsuya,Kagawa Eisuke,Dai Kazuoki,Aokage Toshiyuki,Matsushita Junichi,Ikenaga Hiroki

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1532-5415.2008.01781.x/fullpdf

Reference8 articles.

1. Licorice-induced pseudoaldosteronism;Conn;JAMA,1968

2. Licorice-induced hypermineralocorticoidism;Farese;N Engl J Med,1991

3. Effects of long term administration of Shakuyaku-kanzo-To and Shosaiko-To on rerum potassium levels;Homma;Yakugaku Zasshi,2006

4. Severe hypokalemia, rhabdomyolysis, muscle paralysis, and respiratory impairment in a hypertensive patient taking herbal medicines containing licorice;Yasue;Intern Med,2007

5. Life-threatening ventricular tachycardia due to liquorice-induced hypokalaemia;Eriksson;J Intern Med,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of compound glycyrrhizin in the patients with vitiligo: a systematic review and meta-analysis;Expert Review of Clinical Pharmacology;2023-05-23

2. Recent advances in glycyrrhizin metabolism, health benefits, clinical effects and drug delivery systems for efficacy improvement; a comprehensive review;Phytomedicine;2022-05

3. Geriatric Patients Are at a High Risk of Hypokalemia Associated with Yokukansan Preparation: A Retrospective Cohort Study;Biological and Pharmaceutical Bulletin;2020-11-01

4. Case of hypokalemic paralysis due to use of drug containing therapeutic doses liquorice root;Neuromuscular Diseases;2020-01-10

5. Hypoxic Trophoblast HMGB1 Induces Endothelial Cell Hyperpermeability via the TRL-4/Caveolin-1 Pathway;The Journal of Immunology;2014-10-22